In the interventional cardiology setting, what percentage of your patients do not achieve the ESC Lipid Guideline goal of 70 mg/dL and, therefore, are suitable candidates for PCSK9 inhibition? Can you discuss your patient selection process?
Presenter
Chairman of Medicine Department of Cardiology, Angiology, and Nephrology J. W. Goethe University Frankfurt, Germany